Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®
Status:
Completed
Trial end date:
2017-06-02
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare patient medication satisfaction as measured
by the Medication Satisfaction Questionnaire (MSQ) scores between the Copaxone 40 mg/mL three
time a week (TIW) group and the Copaxone 20 mg/mL once daily (QD) group over 6 months of
treatment.